Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

作者：Hossein Jadvar, Jérémie Calais, Stefano Fanti, Felix Y. Feng, Kirsten L. Greene, James L. Gulley, Michael S. Hofman, Bridget F. Koontz, Daniel W. Lin, Michael J. Morris, Steve P. Rowe, Trevor J. Royce, Simpa S. Salami, Bital Savir-Baruch, Sandy Srinivas, Thomas A. Hope · 发表于：Journal of Nuclear Medicine · 年份：2021 · DOI：10.2967/jnumed.121.263262 · 被引用次数：154 · 研究领域：Prostate Cancer Treatment and Research、Prostate Cancer Diagnosis and Treatment、Radiopharmaceutical Chemistry and Applications

Prostate cancer is the most common cancer diagnosis in men in the United States and a leading cause of cancer-related morbidity and mortality ([ 1 ][1]). It can exist along a wide spectrum of aggressiveness and severity, from indolent, very-low-risk, localized prostate cancer to life-threatening,